Regenxbio Inc (RGNX)

NASDAQ
35.95
-0.36(-0.99%)
After Hours
35.95
-0.05(-0.14%)
- Real-time Data
  • Volume:
    215,253
  • Bid/Ask:
    26.50/37.19
  • Day's Range:
    35.60 - 36.78

RGNX Overview

Prev. Close
36.31
Day's Range
35.6-36.78
Revenue
161.28M
Open
36.78
52 wk Range
26.4-50.13
EPS
-3.56
Volume
215,253
Market Cap
1.55B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
485,021
P/E Ratio
-
Beta
1.08
1-Year Change
28.71%
Shares Outstanding
42,600,528
Next Earnings Date
Nov 10, 2021
What is your sentiment on Regenxbio Inc?
or
Market is currently closed. Voting is open during market hours.

Regenxbio Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellSellSell
Technical IndicatorsStrong SellNeutralBuySellSell
SummaryStrong SellNeutralNeutralSellSell

Regenxbio Inc Company Profile

Regenxbio Inc Company Profile

Employees
306

REGENXBIO Inc. is a clinical-stage biotechnology company. The Company's gene therapy product candidates are designed to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. The Company develops products candidates across the therapeutic areas of metabolic, neurodegenerative and retinal diseases. Its product candidate, RGX-314, is meant for the treatment of wet age-related macular degeneration (wet AMD). Its product candidate, RGX-501, is meant for the treatment of homozygous familial hypercholesterolemia (HoFH). It is also developing product candidates, such as RGX-111 and RGX-121, to address the neurological symptoms of two severe genetic lysosomal storage diseases, Mucopolysaccharidosis Type I (MPS I) and Mucopolysaccharidosis Type II (MPS II), respectively. Its product candidates utilize viral vectors from its gene delivery platform, NAV Technology Platform.

Read More
  • https://www.reddit.com/r/MicrocapStocksRun/comments/p1otr4/regenxbio_inc_a_compelling_investment_opportunity/?utm_source=share&utm_medium=web2x&context=3
    0
    • It. It is going up FOREVER! The new PARADIGM. IT IS DIFFERENT THIS TIME!
      1
      • RGNX is fully priced and a short sale
        0
        • RGNX is going to 32.50
          1
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.